Symptom-based staging for logopenic variant primary progressive aphasia.

Symptom-based staging for logopenic variant primary progressive aphasia.

Publication date: Jul 01, 2024

Logopenic variant primary progressive aphasia (lvPPA) is a major variant presentation of Alzheimer’s disease (AD) that signals the importance of communication dysfunction across AD phenotypes. A clinical staging system is lacking for the evolution of AD-associated communication difficulties that could guide diagnosis and care planning. Our aim was to create a symptom-based staging scheme for lvPPA, identifying functional milestones relevant to the broader AD spectrum. An international lvPPA caregiver cohort was surveyed on symptom development under an ‘exploratory’ survey (34 UK caregivers). Feedback from this survey informed the development of a ‘consolidation’ survey (27 UK, 10 Australian caregivers) in which caregivers were presented with six provisional clinical stages and feedback was analysed using a mixed-methods approach. Six clinical stages were endorsed. Early symptoms included word-finding difficulty, with loss of message comprehension and speech intelligibility signalling later-stage progression. Additionally, problems with hearing in noise, memory and route-finding were prominent early non-verbal symptoms. ‘Milestone’ symptoms were identified that anticipate daily-life functional transitions and care needs. This work introduces a new symptom-based staging scheme for lvPPA, and highlights milestone symptoms that could inform future clinical scales for anticipating and managing communication dysfunction across the AD spectrum.

Concepts Keywords
Alzheimer Aged
Australian Aged, 80 and over
Caregivers Alzheimer Disease
Daily Alzheimer’s disease
Stage Aphasia, Primary Progressive
Australia
Caregivers
Cohort Studies
Disease Progression
Female
Humans
logopenic
Male
Middle Aged
primary progressive aphasia
staging

Semantics

Type Source Name
disease IDO symptom
disease MESH primary progressive aphasia
disease MESH Alzheimer’s disease
pathway KEGG Alzheimer disease
disease MESH Disease Progression

Original Article

(Visited 2 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *